ARWR
Arrowhead Pharmaceuticals Inc
65.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.15 | 0.03 | 0.00 | 0.00 | 0.19 | 0.02 | 4.04 | 0.20 | 1.89 | 1.88 | 0.52 | 0.52 | 4.67 | |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | – | – | |
| 0.11 | -0.01 | -0.04 | -0.04 | -0.04 | 0.02 | 4.04 | 0.20 | 1.89 | 1.88 | 0.52 | 0.52 | 4.67 | |
| 0.90 | 1.05 | 0.79 | 1.19 | 1.08 | 1.10 | 0.99 | 1.17 | 1.29 | 1.26 | 1.22 | 1.38 | 5.05 | |
| 0.23 | 0.22 | 0.20 | 0.19 | 0.21 | 0.21 | 0.21 | 0.22 | 0.27 | 0.32 | 0.29 | 0.33 | 1.19 | |
| 1.12 | 1.26 | 0.99 | 1.38 | 1.29 | 1.31 | 1.20 | 1.39 | 1.56 | 1.59 | 1.51 | 1.71 | 6.25 | |
| -1.01 | -1.27 | -1.02 | -1.42 | -1.33 | -1.29 | 2.83 | -1.19 | 0.33 | 0.29 | -0.99 | -1.19 | -1.58 | |
| 0.05 | 0.05 | 0.06 | 0.04 | 0.12 | 0.17 | 0.16 | 0.18 | 0.16 | 0.16 | 0.17 | 0.17 | 0.65 | |
| -1.02 | -1.29 | -1.03 | -1.40 | -1.42 | -1.40 | 2.75 | -1.29 | 0.27 | 0.20 | -0.97 | -1.25 | -1.76 | |
| 0.02 | -0.03 | -0.01 | -0.03 | 0.00 | 0.00 | 0.01 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.14 | |
| -1.02 | -1.24 | -1.02 | -1.38 | -1.40 | -1.39 | 2.75 | -1.26 | -0.18 | 0.22 | -0.93 | -1.36 | -2.23 | |
| -0.93 | -1.20 | -0.93 | -1.32 | -1.26 | -1.19 | 2.95 | -1.07 | 0.47 | 0.41 | -0.75 | -1.08 | -0.98 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.